Date post: | 22-Aug-2014 |
Category: |
Health & Medicine |
Upload: | aboubakr-mohamed-elnashar |
View: | 372 times |
Download: | 7 times |
Guidelines on management of
iron deficiency in pregnancy
British Committee for Standards in Haematology
2012.
Aboubakr Elnashar, Egypt
Aboubakr Elnashar
1. DEFINITION
2. PREVALENCE
3. EFFECTS
4. DIAGNOSIS
5. PREVENTION
6. MANAGEMENT
Aboubakr Elnashar
1. DEFINITION
1st T:
<11g/dL (WHO, 2001)
2nd and 3rd T:
<10.5 gm
Postpartum:
<10 gm
{relative plasma expansion being particularly marked
in the second trimester}
Mild Moderate Severe Adam , 2005
9-11 7-9 <7 Hgb g/dl
Aboubakr Elnashar
2. PREVALENCE
IDA:
Most common cause
30- 40% pregnant women
(WHO, 2008).
Aboubakr Elnashar
3. EFFECTS
Maternal
{immune function}
1. Increased susceptibility or severity of infections (Eliz et al, 2005)
2. Poor work capacity and performance (Haas et al, 2001)
3. Disturbances of postpartum cognition and
emotions (Beard et al, 2005).
Aboubakr Elnashar
Pregnancy outcome
1. PTD (Scholl et al, 1994)
2. Low birth wt (Cogswell et al, 2003)
3. Placental abruption
4. Increased peripartum blood loss (Arnold et al, 2009).
Aboubakr Elnashar
Fetus:
protected from the effects of iron deficiency by
upregulation of placental iron transport proteins (Gambling et al, 2001)
Infant:
increases the risk of iron deficiency in the first 3
months of life (Puolakka et al, 1980, Colomer et al, 1990).
Aboubakr Elnashar
4. DIAGNOSIS
Clinical
usually nonspecific, unless the anaemia is severe.
1. Fatigue: most common symptom.
2. Pallor, weakness, headache, palpitations,
dizziness, dyspnoea and irritability.
3. Feel colder than normal {Impair temperature
regulation} 4. Rarely pica develops, where there is a craving for non-
food items such as ice and dirt.
Aboubakr Elnashar
Laboratory tests
1. CBC:
At booking
At 28 w (NICE, 2008).
low Hb, MCV, MCH, and MCHC
Blood film:
microcytic hypochromic red cells
characteristic ‘pencil cells’.
N.B: microcytic, hypochromic indices may
also occur in haemoglobinopathies.
Aboubakr Elnashar
H=hypochromic RBC; p=pencil RBC; T=target RBC; M=microcytic RBC The Lancet 2000;355:1260
Iron Deficiency Anemia
Aboubakr Elnashar
2. Serum ferritin
Accurately reflects iron stores in the absence of
inflammatory change.
≤ 15 μg/l: iron depletion
≤ 30 μg/l: early iron depletion which will worsen
unless treated: Treatment should be considered (van den Broek et al, 1998).
Aboubakr Elnashar
Indications for assessment of serum ferritin
I. Anaemic women where estimation of iron stores is
necessary
1. Known Haemoglobinopathy
2. Prior to parenteral iron replacement
II. Non-anaemic women with high risk of iron depletion 1. Previous anaemia 2. Multiparity >P3 3. Consecutive pregnancy <1year following delivery 4. Vegetarians 5. Teenage pregnancies 6. Recent history of bleeding
III. Non-anaemic women where estimation of iron stores is necessary 1. High risk of bleeding 2. Jehovah’s witnesses
Aboubakr Elnashar
3.Trial of Iron therapy
Diagnostic and therapeutic for normocytic or
microcytic anaemia
Ferritin should be checked first In the presence of
known haemoglobinopathy,
If no improvement in Hb by 2 ws:
referral to consider other causes of anaemia, such
as folate deficiency.
Aboubakr Elnashar
5. PREVENTION
Universal supplementation
From booking (WHO) or
From 2nd T (INACG) (Stolzfus et al, 1998; WHO, 2001). Cochrane review (2009):
Iron supplementation improved birth length Apgar scores infant ferritin at 3 months reduces the need for postpartum maternal transfusion iron–folic acid supplementation improved birth weight.
Aboubakr Elnashar
6. MANAGEMENT
1. Dietary Advice
Diet rich in iron
Avoid inhibitors of iron absorption
Poor Medium Rich
milk and its
products, root
vegetables
meat, chicken,
fish, spinach,
banana, apple
liver, egg yolk, dry
beans, dry fruits,
wheat germ, yeast
Enhance Inhibit
Heme Phytates: cereals
Ascorbic acid Tannins: tea –coffee
Ferrous iron(Fe2+) Calcium
Aboubakr Elnashar
2. Oral Iron Patil et al, 2012: I J Med Pharmaceutical Sci
I. Conventional iron preparations
Fe sulfate, Fe fumarate.
Cheap.
No scientific evidence that any particular brand is
better .
Should not be given with food
{salts bind the iron: impair absorption}
Side effects
40%
Nausea, vomiting, heart burn, metallic taste,
constipation, abdominal cramps, diarrhea.
10%: Discontinue Aboubakr Elnashar
Extended (slow) release capsules or enteric
coated capsules
Less side effect
{slow/decreased iron absorption, absorbed lower
parts of the GI}
{Iron absorption occurs at the duodenum and
proximal jejunum}
Not very effective
Should be avoided
{majority of the iron is carried past the duodenum:
limiting absorption} (Tapiero, 2001).
Aboubakr Elnashar
II. New iron preparations
Multi Amino Acid Chelated iron, Carbonyl iron,
Iron polymaltose, others……….
Multi Amino Acid Chelated iron Vs iron salt (Pineda et al, 1994; Sofia et al, 2001)
Low GIT intolerance
Increase Hbg level faster with significant low
doses
High bioavailability and regulation
Better improve iron stores
Higher cost.
Aboubakr Elnashar
{Higher stability of amino acid chelate:
prevents the molecule from being destroyed in the
gut}: less GI irritation
{Atomic structure and chemistry}:
protects the ferrous iron from undesirable chemical
reactions in the stomach and intestine that limit iron
absorption.
Absorption
not reduced in presence of phytates.
Aboubakr Elnashar
Oral iron should be taken
On an empty stomach, 1 h before meals
With a source of vitamin C: orange juice {maximise absorption}.
Other medications or antacids should not be
taken at the same time (1A).
Aboubakr Elnashar
Response to oral iron
Hgb should rise by 2.0 g/l over 3-4w (British National Formulary, 2010).
Oral therapy should be continued for 3 months
after anemia has been corrected
{replenish iron stores},
Aboubakr Elnashar
Failure to respond to oral iron
Incorrect diagnosis:
thalassemia
Presence of a coexisting disease interfering with
response:
anemia of chronic disease, renal failure
Patient is not taking the medication
Medication is not being absorbed:
enteric coated tablets, concomitant use of antacids, malabsorption
Iron (blood) loss or need is in excess of the amount
ingested:
severe continuous GI bleeding, dialysis patient
Aboubakr Elnashar
3. Parenteral Iron Therapy
Indication
From the 2nd T onwards and postpartum period
1. Failure to respond
2. Intolerant of oral iron (1A).
3. Proven malabsorption
Dose calculated based on
Pre-pregnancy wt,
Target Hb of 11.0 g/l (1B).
Potential side effects
written information. Skin discoloration
Local abscess
Allergic reaction
Iron over load.
Aboubakr Elnashar
Parenteral Vs oral iron:
Faster increases in Hbg
Better replenishment of iron stores, particularly
iron sucrose (Al et al, 2005; Bhandal et al, 2006) and iron (III) carboxymaltose (Van Wyk et al, 2007; Breymann et al, 2007, Shafi et al, 2012)
Equivalent increases in Hbg (Bayouneu and colleagues, 2002; Sharma and co-workers, 2004).
Aboubakr Elnashar
4. Blood transfusion:
Red cells (preferred) or whole blood
Indications: rare
1. Severe anemia near term { maximum rise in hgb achievable with either oral or parenteral iron is
0.8 g/ dL/wk}.
2. Other complication: placenta previa
3. Hypovolemia from blood loss
4. Emergency operation on a severely anemic
woman.
Aboubakr Elnashar
Anaemia at the time of delivery
1) Delivery in an hospital setting
2) Available intravenous access
3) Blood group-and-save
4) Active management of 3rd stage of labour
5) Plans to deal with excessive bleeding.
Aboubakr Elnashar
Postnatal anaemia
WHO: Hb <10g/dl.
CBC should be checked within 48 h of delivery in
1. Estimated blood loss≥ 500ml
2. Uncorrected anaemia in ANC
3. Symptoms suggestive of postpartum anaemia.
Oral iron: for at least 3 months
Repeat CBC and ferritin
{ensure Hb and iron stores are replete}.
Aboubakr Elnashar
Thank you
Aboubakr Elnashar